Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury.
- Published In:
- Journal of the American Society of Nephrology : JASN, 22(6), 1041-52 (2011)
- Authors:
- Szeto, Hazel H(7), Liu, Shaoyi(2), Soong, Yi(2), Wu, Dunli, Darrah, Shaun F, Cheng, Feng-Ying, Zhao, Zhihong, Ganger, Michael, Tow, Clara Y, Seshan, Surya V
- Database ID:
- RPEP-01869
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01869APA
Szeto, Hazel H; Liu, Shaoyi; Soong, Yi; Wu, Dunli; Darrah, Shaun F; Cheng, Feng-Ying; Zhao, Zhihong; Ganger, Michael; Tow, Clara Y; Seshan, Surya V. (2011). Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury.. Journal of the American Society of Nephrology : JASN, 22(6), 1041-52. https://doi.org/10.1681/ASN.2010080808
MLA
Szeto, Hazel H, et al. "Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury.." Journal of the American Society of Nephrology : JASN, 2011. https://doi.org/10.1681/ASN.2010080808
RethinkPeptides
RethinkPeptides Research Database. "Mitochondria-targeted peptide accelerates ATP recovery and r..." RPEP-01869. Retrieved from https://rethinkpeptides.com/research/szeto-2011-mitochondriatargeted-peptide-accelerates-atp
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.